Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
38.88
-0.85 (-2.14%)
At close: Dec 26, 2025, 4:00 PM EST
38.53
-0.35 (-0.90%)
After-hours: Dec 26, 2025, 4:32 PM EST
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.91 billion as of December 26, 2025. Its market cap has increased by 463.64% in one year.
Market Cap
5.91B
Enterprise Value
5.58B
1-Year Change
463.64%
Ranking
Category
Stock Price
$38.88
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.91B, an increase of 4,659.56%. That is a compound annual growth rate of 102.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 5.91B | 586.48% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |